Posts published in “Psilocybin”

Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli

Abstract: Traditional psychedelics are undergoing a transformation from recreational drugs, to promising pharmaceutical drug candidates with the potential to provide an alternative treatment option for…

Enzymatic Synthesis of Psilocybin

Production Options for Psilocybin: Making of the Magic

Psilocybin: The most effective moral bio-enhancer?

Synthesis of Baeocystin, a natural Psilocybin Analogue

Psilocybin’s effects on cognition and creativity: A scoping review

The evolution and ecology of psilocybin in nature

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants

Psychedelics promote plasticity by directly binding to BDNF receptor TrkB

Psychedelics reopen the social reward learning critical period

Is Microdosing a Placebo?

The Evolution and Ecology of Psilocybin in Nature

Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis

Studying Harms Is Key to Improving Psychedelic-Assisted Therapy-Participants Call for Changes to Research Landscape

Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors

DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites

Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples

Microdosing psychedelics – Does it have an impact on emodiversity?

Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis

Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity

Hopelessness, Suicidality, and Co-Occurring Substance Use among Adolescent Hallucinogen Users-A National Survey Study

Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome

Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice

Lower-dose psycholytic therapy – A neglected approach

Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption

Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway

DARK Classics in Chemical Neuroscience: Psilocybin

Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness

Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults

Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation